查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967938

全球小鼠模型技術市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Mice Model Technologies Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計小鼠模型技術市場將從 2025 年的 28.5 億美元成長到 2034 年的 56.5 億美元，2026 年至 2034 年的複合年成長率為 7.91%。

由於製藥和生物技術領域臨床前研究活動的增加，全球小鼠模型技術市場正穩定擴張。對疾病特異性和人源化小鼠模型的需求不斷成長，正在增強腫瘤學、免疫學和遺傳疾病領域的研究能力。藥物發現和轉化研究投入的增加進一步加速了市場發展。學術研究機構和受託研究機構是這項持續需求的主要貢獻者。

主要成長要素包括基因組編輯技術的進步，特別是基於CRISPR的基因編輯技術，這些技術實現了快速、精準的模型建構。臨床前試驗服務外包的增加以及對安全性數據更嚴格的監管要求也推動了相關技術的應用。免疫腫瘤學研究和個人化醫療方法的興起進一步增加了對先進基因工程模型的需求。

展望未來，人源化小鼠平台的改進和整合數據分析服務的提供預計將對市場產生積極影響。儘管倫理考量和替代測試技術可能會影響成長趨勢，但體內研究的重要性仍然不變。提案更快模型建構速度、專用品系和全面研究服務的公司有望鞏固其市場地位。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球小鼠模型技術市場：依技術分類

  • 市場分析、洞察與預測
  • CRISPR基因敲除
  • CRISPR基因敲入
  • 隨機插入
  • 大規模、有針對性的插入
  • ES細胞修飾（同源重組）
  • 其他

第5章：全球小鼠模型技術市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥公司
  • 生技公司
  • 學術研究設施
  • 合約研究和製造組織

第6章 全球小鼠模型技術市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Biocytogen
    • Charles River Laboratories
    • Cyagen Biosciences
    • Gempharmatech
    • GenOway
    • Ingenious Targeting Laboratory
    • Merck KGaA
    • Ozgene Pty Ltd
    • Taconic Biosciences Inc
    • PolyGene AG
    • The Jackson Laboratory
簡介目錄
Product Code: VMR11219536

The Mice Model Technologies Market size is expected to reach USD 5.65 Billion in 2034 from USD 2.85 Billion (2025) growing at a CAGR of 7.91% during 2026-2034.

The Global Mice Model Technologies Market is expanding steadily due to increasing preclinical research activities in pharmaceuticals and biotechnology. Rising demand for disease-specific and humanized mouse models has strengthened research capabilities in oncology, immunology, and genetic disorders. Growing investments in drug discovery and translational research are further accelerating market development. Academic research institutions and contract research organizations are key contributors to sustained demand.

Major growth drivers include advancements in genome-editing technologies, particularly CRISPR-based modifications, which enable rapid and precise model development. Increased outsourcing of preclinical testing services and stricter regulatory requirements for safety data are also fueling adoption. The rise of immuno-oncology research and personalized medicine approaches further increases demand for advanced and genetically engineered models.

Looking ahead, the market is expected to benefit from improved humanized mouse platforms and integrated data analytics services. Ethical considerations and alternative testing technologies may influence growth dynamics, but whole-organism research will remain critical. Companies offering faster model generation, specialized strains, and comprehensive research services are likely to strengthen their market position.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • CRISPR Knockout
  • CRISPR Knockin
  • Random Insertions
  • Large, Targeted Insertions
  • ES Cell Modification (Homologous Recombination)
  • Others

By End-User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Facilities
  • Contract Research and Manufacturing Organizations

COMPANIES PROFILED

  • Biocytogen, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Merck KGaA, Ozgene Pty Ltd, Taconic Biosciences Inc, PolyGene AG, The Jackson Laboratory
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL MICE MODEL TECHNOLOGIES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. CRISPR Knockout Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. CRISPR Knockin Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Random Insertions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Large, Targeted Insertions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. ES Cell Modification (Homologous Recombination) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MICE MODEL TECHNOLOGIES MARKET: BY END-USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-user
  • 5.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Academic and Research Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Contract Research and Manufacturing Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MICE MODEL TECHNOLOGIES MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Technology
    • 6.2.2 By End-user
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Technology
    • 6.3.2 By End-user
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Technology
    • 6.4.2 By End-user
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Technology
    • 6.5.2 By End-user
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Technology
    • 6.6.2 By End-user
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL MICE MODEL TECHNOLOGIES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Biocytogen
    • 8.2.2 Charles River Laboratories
    • 8.2.3 Cyagen Biosciences
    • 8.2.4 Gempharmatech
    • 8.2.5 GenOway
    • 8.2.6 Ingenious Targeting Laboratory
    • 8.2.7 Merck KGaA
    • 8.2.8 Ozgene Pty Ltd
    • 8.2.9 Taconic Biosciences Inc
    • 8.2.10 PolyGene AG
    • 8.2.11 The Jackson Laboratory